Company Filing History:

13 out of 1,777

Novo Nordisk A/s

Bayer Aktiengesellschaft

patents

Years Active: 1989-2002

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6482798 - Aprotinin variants having improved properties (2002-11-19),

2. 5783416 - Human spasmolytic polypeptide in glycosylated form (1998-07-21),

3. 5629176 - Human Kunitz-type protease inhibitor variants (1997-05-13),

4. 5621074 - Aprotinin analogs (1997-04-15),

5. 5618915 - Aprotinin analogs (1997-04-08),

6. 5618913 - Insulin analogues (1997-04-08),

7. 5618696 - Human kunitz-type protease inhibitor and variants thereof (1997-04-08),

8. 5591603 - Process for preparing aprotinin and aprotinin analogs in yeast cells (1997-01-07),

9. 5576294 - Human Kunitz-type protease inhibitor variant (1996-11-19),

10. 5514585 - Yeast processing system (1996-05-07),

11. 5510249 - Yeast processing system (1996-04-23),

12. 5395922 - Yeast processing system (1995-03-07),

13. 5373090 - Aprotinin analogues and a process for the production thereof (1994-12-13),

14. 5008241 - Novel insulin peptides (1991-04-16),

15. 4916212 - DNA-sequence encoding biosynthetic insulin precursors and process for (1990-04-10),

Title: The Innovative Journey of Kjeld Norris: A Patent Powerhouse from Hellerup, DK

Introduction: Kjeld Norris is a prominent inventor hailing from Hellerup, Denmark, with an impressive portfolio of 16 patents to his name. His contributions to the field of biochemistry and pharmaceuticals have been significant, showcasing his prowess as both a scientist and inventor.

Latest Patents: Two of his latest patents highlight his innovative spirit. The first patent involves "Aprotinin variants having improved properties," which focuses on the enzyme-inhibitory, immunological, and pharmacokinetic enhancements of aprotinin. The second patent is titled "Human spasmolytic polypeptide in glycosylated form," reflecting his ongoing commitment to developing solutions within the therapeutic realm.

Career Highlights: Throughout his career, Kjeld Norris has been associated with leading companies such as Novo Nordisk A/S and Novo Industri A/S. His roles in these institutions have allowed him to make significant breakthroughs in pharmaceutical advances, particularly in the area of polypeptide research.

Collaborations: Kjeld has collaborated with notable colleagues, including Fanny Norris and Lars Christian Petersen, demonstrating the importance of teamwork in innovation. These partnerships have likely contributed to his success, fostering an environment that promotes creativity and cutting-edge research.

Conclusion: Kjeld Norris stands out as a distinguished inventor whose work continues to impact the fields of biochemistry and pharmaceuticals. With his considerable number of patents and collaborations with reputed firms and professionals, he remains a key figure to watch in the evolving landscape of medical innovations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.